Short Interest in Fresenius SE & Co. (OTCMKTS:FSNUY) Drops By 88.7%

Fresenius SE & Co. (OTCMKTS:FSNUY) saw a large decline in short interest in the month of December. As of December 31st, there was short interest totaling 11,203 shares, a decline of 88.7% from the December 15th total of 98,734 shares. Based on an average trading volume of 48,099 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.0% of the shares of the company are short sold. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 48,099 shares, the days-to-cover ratio is currently 0.2 days.

Analyst Ratings Changes

A number of research analysts recently issued reports on FSNUY shares. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Fresenius SE & Co. in a report on Monday, October 27th. Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, December 15th. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Fresenius SE & Co. currently has an average rating of “Buy”.

Fresenius SE & Co. Price Performance

Shares of FSNUY stock traded up $0.50 during mid-day trading on Monday, reaching $14.82. The company’s stock had a trading volume of 24,582 shares, compared to its average volume of 50,529. The firm’s 50-day moving average is $14.31 and its two-hundred day moving average is $13.85. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.99 and a current ratio of 1.26. The company has a market cap of $33.11 billion, a P/E ratio of 26.95 and a beta of 0.76. Fresenius SE & Co. has a 1-year low of $8.80 and a 1-year high of $33.93.

Fresenius SE & Co. (OTCMKTS:FSNUY) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.02. Fresenius SE & Co. had a net margin of 5.26% and a return on equity of 9.72%. The firm had revenue of $6.29 billion during the quarter, compared to the consensus estimate of $6.38 billion. On average, research analysts predict that Fresenius SE & Co. will post 0.79 earnings per share for the current year.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.